Skip to content
Screener

Globus Medical GMED Total Cost of Revenue

Discontinued — last reported Q2 '26

Total Cost of Revenue at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$8.05B+5.5%
Stryker logo
StrykerSYK
$2.09B-4.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$61.23M-3.7%
Boston Scientific logo
Boston ScientificBSX
$1.59B-2.6%
IAR
Integra LifeSciencesIART
$199.02M-3.5%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$635.5M+7.3%

Segments

By segment

See full
Reportable Segment$210.51M-1.2%

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$10.93B+52.9%
Enterprise value$10.54B+49.6%
P/E20.4×+0.4×
P/S3.5×+0.8×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(In thousands, except per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net sales$789,612$745,342$1,549,466$1,343,463
Cost of Sales and Operating expenses:
Cost of sales (exclusive of amortization of intangibles)241,439248,765475,505444,162
Research and development36,32139,95472,83173,016
Selling, general and administrative286,823303,622584,598546,421
Amortization of intangibles29,56030,18959,08658,991
Acquisition-related costs11,08033,15617,45734,213
Restructuring costs1,95713,5477,16913,547

Item 1. Financial Statements

FAQ

What is Globus Medical's total cost of revenue?
Globus Medical (GMED) reported total cost of revenue of $241.44M in Q2 2026.
How has Globus Medical's total cost of revenue changed year-over-year?
Globus Medical's total cost of revenue decreased by 2.9% year-over-year, from $248.77M to $241.44M.
What is the long-term trend for Globus Medical's total cost of revenue?
Over 4 years (2021 to 2025), Globus Medical's total cost of revenue has grown at a 41.5% compound annual growth rate (CAGR), from $239.22M to $957.8M.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Ask your AI about Globus Medical's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude